Valuation: Ipsen

Market Cap 1.28TCr 1.47TCr 1.21TCr 1.1TCr 2.05TCr 1,40700Cr 2.06TCr 14TCr 5.58TCr 72TCr 5.51TCr 5.38TCr 2,30100Cr P/E 2026 *
13x
P/E 2027 * 13.3x
Enterprise Value 1.15TCr 1.32TCr 1.09TCr 989.84Cr 1.85TCr 1,27000Cr 1.86TCr 13TCr 5.04TCr 65TCr 4.97TCr 4.86TCr 2,07800Cr EV / Sales 2026 *
2.54x
EV / Sales 2027 * 2.26x
Free-Float
40.65%
Yield 2026 *
0.98%
Yield 2027 * 0.98%
1 day+0.55%
1 week-0.95%
Current month-4.40%
1 month-4.93%
3 months+1.56%
6 months-0.89%
Current year+31.68%
1 week 154.1
Extreme 154.1
160.9
1 month 154.1
Extreme 154.1
170.3
Current year 116
Extreme 116
176.6
1 year 109
Extreme 109
176.6
3 years 88.05
Extreme 88.05
176.6
5 years 77.28
Extreme 77.28
176.6
10 years 35.52
Extreme 35.52
176.6
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%-0.95% - - 1.47TCr
+0.04%+3.34%+51.12%+101.82% 1,02800Cr
-0.09%+1.66%+55.02%+66.18% 65TCr
-0.02%+2.66%+18.91%+71.47% 47TCr
-1.22%+3.66%+36.44%+38.32% 35TCr
-0.79%+2.73%+19.03%+25.08% 27TCr
+0.58%+6.76%+11.13%+16.52% 26TCr
+1.55%+2.20%+39.81%+46.55% 21TCr
+0.79%+1.84%-28.27%-56.71% 19TCr
-0.52%+4.45%+32.12%+98.51% 19TCr
Average +0.24%+3.26%+26.15%+45.30% 40.02TCr
Weighted average by Cap. +0.23%+3.09%+35.15%+61.76%

Financials

2026 *2027 *
Net sales 454.34Cr 521.04Cr 429.01Cr 389.57Cr 729.89Cr 50TCr 732.94Cr 5.14TCr 1.98TCr 25TCr 1.96TCr 1.91TCr 82TCr 463.7Cr 531.76Cr 437.84Cr 397.59Cr 744.92Cr 51TCr 748.03Cr 5.24TCr 2.02TCr 26TCr 2TCr 1.95TCr 83TCr
Net income 101.07Cr 115.91Cr 95Cr 87Cr 162.37Cr 11TCr 163.05Cr 1.14TCr 441.14Cr 5.65TCr 435.4Cr 425.74Cr 18TCr 99Cr 113Cr 93Cr 84Cr 158.3Cr 11TCr 158.96Cr 1.11TCr 430.09Cr 5.51TCr 424.5Cr 415.07Cr 18TCr
Net Debt -123.8Cr -141.97Cr -116.9Cr -106.15Cr -198.88Cr -14TCr -199.71Cr -1.4TCr -540.34Cr -6.93TCr -533.32Cr -521.48Cr -22TCr -229.94Cr -263.7Cr -217.12Cr -197.16Cr -369.4Cr -25TCr -370.94Cr -2.6TCr -1TCr -13TCr -990.58Cr -968.58Cr -41TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
18/26/18 €155.90 +0.45% 6,781
17/26/17 €155.20 -2.76% 25,993
16/26/16 €159.60 -0.81% 1,25,208
15/26/15 €160.90 +1.64% 67
14/26/14 €158.30 +0.32% 147
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
155.90EUR
Average target price
166.07EUR
Spread / Average Target
+6.52%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!